Lazo-Langner A, Louzada M, Garg A, et al. Assessing the risk-benefit of anticoagulants in elkderly patients with cancer-associated venous thromboembolism; a population based study. EHA 2017, abstract S441.
Overlevingsvoordeel met brentuximab vedotine bij stadium III/IV hodgkinlymfoom
sep 2022 | Lymfoom